1 document found, page 1 of 1

Sort by Issue Date

Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endosc...

Magro, F; Lopes, S; Silva, M; Coelho, R; Portela, F; Branquinho, D; Correia, L; Fernandes, S; Cravo, M; Caldeira, P; Sousa, H T; Patita, M; Lago, P

Background and aims: Golimumab has an established exposure-response relationship in patients with ulcerative colitis [UC]. However, the association of serum golimumab trough levels [TL] with objective markers of disease activity, such as endoscopic and histological activity scores and concentrations of biomarkers, remains less understood. This report describes the relationship of serum golimumab TL at the end o...


1 Results

Queried text

Refine Results

Author





















Date


Document Type


Access rights


Resource


Subject